Digistain logo (teal)
  • Platform
    • Overview
    • How it works
    • Research and pipeline
    • Publications
  • Products
    • Digistain Breast
  • Partners
  • Investors
  • About
    • About Digistain
    • Team
  • News
  • Contact
✕
  • Platform
    • Overview
    • How it works
    • Research and pipeline
    • Publications
  • Products
    • Digistain Breast
  • Partners
  • Investors
  • About
    • About Digistain
    • Team
  • News
  • Contact
Contact us

Digistain

  • Home
  • News
  • Digistain
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Awards
  • Conferences
  • Digistain
  • Funding
  • Healthcare
  • News
  • All
  • All
  • admin
September 10, 2021
dsv 1
September 10, 2021
Categories
  • Digistain

Darius Francescatti joining as advisor

Announcing our new team member – Darius Francescatti, a breast surgeon who brings to Digistain 20+ years of experience in breast cancer management. Prof Darius Francescatti […]
Do you like it?
Read more
Digistain

Digistain is a cancer biomarker company. Its breast cancer recurrence-risk test measures the tumour’s biochemistry directly, with results before the next appointment.

LRQA certified ISO 13485

Platform

  • Overview
  • How it works
  • Research and pipeline
  • Publications

Digistain Breast

  • Overview
  • For clinicians
  • For laboratories
  • For patients

Company

  • Partners
  • Investors
  • About
  • Team
  • News
  • Contact
© 2026 Digistain Ltd · ISO 13485:2016 certified (LRQA) for the design and development of IVD software used in cancer management · Privacy policy · Terms and conditions · Cookie policy